Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease (Q63587316)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease |
clinical trial |
Statements
PRINCE (English)
0 references
Phase 2a Multicenter Randomized Double-Blind Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Oral PRV-6527 (JNJ-40346527), an Inhibitor of CSF-1 Receptor, in Subjects With Moderately to Severely Active Crohn's (English)
0 references
20 March 2018
0 references
September 2019
0 references
93
0 references
18 year
0 references
75 year
0 references